These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9816121)

  • 1. Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin 3 fusion protein, on human tumor colony-forming units taken directly from patients.
    Izquierdo MA; Degen D; Raymond E; Caron D; Ortiz V; Banks P; Von Hoff DD
    Clin Cancer Res; 1996 Oct; 2(10):1713-6. PubMed ID: 9816121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIXY321 (GM-CSF/IL-3 fusion protein): biology and early clinical development.
    Vadhan-Raj S
    Stem Cells; 1994 May; 12(3):253-61. PubMed ID: 8075592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic effects and clinical uses of granulocyte-macrophage colony-stimulating factor and PIXY321.
    Anderson JE; Appelbaum FR
    Curr Opin Hematol; 1994 May; 1(3):203-9. PubMed ID: 9371283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on human polymorphonuclear leukocyte function.
    Buescher ES; McIlheran SM; Banks SM; Vadhan-Raj S
    Exp Hematol; 1993 Oct; 21(11):1467-72. PubMed ID: 8405227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro assessment of the effects of granulocyte-macrophage colony-stimulating factor on primary human tumors and derived lines.
    Foulke RS; Marshall MH; Trotta PP; Von Hoff DD
    Cancer Res; 1990 Oct; 50(19):6264-7. PubMed ID: 2205378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombopoietin and chemokine mRNA expression in patient post-chemotherapy and in vitro cytokine-treated marrow stromal cell layers.
    Schwartz GN; Kammula U; Warren MK; Park MK; Yan XY; Marincola FM; Gress RE
    Stem Cells; 2000; 18(5):331-42. PubMed ID: 11007917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical analysis of tumor cells in pre- and post-culture peripheral blood progenitor cell collections from breast cancer patients.
    Ross AA; Loudovaris M; Hazelton B; Weaver CH; Schwartzberg L; Bender JG
    Exp Hematol; 1995 Dec; 23(14):1478-83. PubMed ID: 8542934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro growth effects of colony-stimulating factors in ovarian cancer.
    Connor JP; Squatrito RC; Terrell KL; Antisdel BJ; Buller RE
    Gynecol Oncol; 1994 Mar; 52(3):347-52. PubMed ID: 7512521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2.
    Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H
    Oncol Rep; 2007 Apr; 17(4):955-61. PubMed ID: 17342342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of GM-CSF, IL-3, and GM-CSF/IL-3 fusion protein on apoptosis of human myeloid leukemic cell line Tf-1 induced by irradiation.
    Yang SR; Wen L; Lu YQ; Gong QY; Yu R; Yao MH
    Acta Pharmacol Sin; 2004 Jan; 25(1):68-75. PubMed ID: 14704125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo.
    Gutschalk CM; Herold-Mende CC; Fusenig NE; Mueller MM
    Cancer Res; 2006 Aug; 66(16):8026-36. PubMed ID: 16912178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
    Ławicki S; Czygier M; Omyła J; Bedkowska E; Szmitkowski M
    Pol Merkur Lekarski; 2007 Oct; 23(136):259-63. PubMed ID: 18293847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
    Ripley D; Tang XM; Ma C; Chegini N
    Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid cytokines as hematopoietic growth factors.
    Williams DE; Park LS; Broxmeyer HE; Lu L
    Int J Cell Cloning; 1991 Nov; 9(6):542-7. PubMed ID: 1770228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.